Report no. 33/2016

Amendment to a significant contract in the subsidiary Zdrowie sp. z o. o.

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19th February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A. informs about signing  annexes to the contracts with the National Health Fund on 30th May 2016  - the Pomorskie Voivodeship Branch in Gdańsk (the Fund Branch) regarding healthcare services such as inpatient care, outpatient specialist care outpatient specialist care (outpatient cost-consuming diagnostic services), primary healthcare in terms of night and holiday care, emergency services as well as primary healthcare –medical transport.

Both the total maximum Fund Branch liability towards the Company and the term of the contracts concluded by Zdrowie sp. z o.o. in Kwidzyń have changed as a result of signing the said annexes.

The Issuer informed about the contracts concluded with the Fund  Branch concerning  healthcare services provided by Zdrowie sp. z o.o. in Kwidzyń in 2016 in its current reports nos. 17/2016 of 16.02.2016 and 31/2016 of 20.05.2016.

The annexes specify the amount of the Fund Branch liability towards the Company for providing the above-mentioned health care services, in the period 1st July to 31st December 2016.

As a result of signing the said annexes,the total maximum Fund Branch liability towards the Company currently amounts to PLN 30,011,095.98 (an increase by PLN 14,942,554.10) for the period 1st January to 31th  December 2016.

As a result of signing the abovementioned annexes to the contract with the NHF concerning providing healthcare services in the period 1st  January to 30th  June 2016, the value of the contract with highest value has changed.

The maximum amount of Fund Branch liability towards the Company in the period 1st  January  to 31st December 2016, as specified in the contract, totals  PLN 22,718,232.52.

The subject of the contract is the provision of healthcare services such as inpatient treatment.  The contract has been concluded for the period 1st  January 2011 to 3th  June 2017.

A criterion for a contract to be considered significant:

 The value of contracts exceeds 10% of the Issuer’s equity capital.